Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,590,037
-
Share change
-
-1,415,127
-
Total reported value
-
$7,111,000
-
Put/Call ratio
-
4%
-
Price per share
-
$0.74
-
Number of holders
-
39
-
Value change
-
-$795,877
-
Number of buys
-
21
-
Number of sells
-
12
Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q3 2018
As of 30 Sep 2018,
ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,590,037 shares.
The largest 10 holders included
Vanguard Group Inc, DLD Asset Management, LP, ESSEX INVESTMENT MANAGEMENT CO LLC, PNC Financial Services Group, Inc., PRELUDE CAPITAL MANAGEMENT, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and Virtu Financial LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.